SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 15th, 2021 • Immucell Corp /De/ • In vitro & in vivo diagnostic substances • New York
Contract Type FiledApril 15th, 2021 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of April 14, 2021, between ImmuCell Corporation, a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).